Trial UPDATE

USA:
Phase III (Diamyd) - 306 patients - Status: recruiting patients
Phase II (NIH/NIDDK) - 126 patients - Status: not started recruitment
TrialNet Prevention Trial - Status: no additional information

Europe:
Phase III (Diamyd) - 306 patients - Status: recruiting patients

Schedule:
For the Phase III trials recruitment is expected to be finalized in April 2009. Results will be available in fall 2010.

The NIH/NIDDK trial is expected to report in 2011.